Cargando…
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy
Immune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte–associated antigen 4 (CTLA-4) and programmed death 1 (PD-1) proteins transformed the management of advanced cancers. Many tumor-intrinsic factors modulate immunological and clinical responses to such therapies, but ample evidence al...
Autores principales: | Davar, Diwakar, Zarour, Hassane M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561605/ https://www.ncbi.nlm.nih.gov/pubmed/35748749 http://dx.doi.org/10.1158/1078-0432.CCR-21-1129 |
Ejemplares similares
-
Immunotherapy of Neuroblastoma: Facts and Hopes
por: Anderson, John, et al.
Publicado: (2022) -
Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative Breast Cancer
por: Nederlof, Iris, et al.
Publicado: (2023) -
TIGIT in cancer immunotherapy
por: Chauvin, Joe-Marc, et al.
Publicado: (2020) -
Epigenetic Regulation in Melanoma: Facts and Hopes
por: Giunta, Emilio Francesco, et al.
Publicado: (2021) -
The Influence of Gut Microbiota on Neurogenesis: Evidence and Hopes
por: Sarubbo, Fiorella, et al.
Publicado: (2022)